2018
DOI: 10.1371/journal.pone.0202045
|View full text |Cite
|
Sign up to set email alerts
|

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets

Abstract: IntroductionMultiple myeloma (MM), a malignant plasma cell disorder, is still an incurable disease. Thus, the identification of novel therapeutic targets is of utmost importance. Here, we evaluated the peripheral blood-based metabolic profile of patients with MM.Material & methodsPeripheral blood plasma levels of 188 endogenous metabolites, including amino acids, biogenic amines, acylcarnitines, glycerophospholipids, sphingomyelins, and hexoses were determined in patients with plasma cell dyscrasias: monoclona… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
42
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(45 citation statements)
references
References 38 publications
2
42
0
1
Order By: Relevance
“…In targeted metabolomics, data cleaning was performed with reference to the criteria used in previous studies [ 32 , 33 ]. Values greater than the limit of detection (LOD) in the raw data of each group were chosen for (semi-) quantification.…”
Section: Methodsmentioning
confidence: 99%
“…In targeted metabolomics, data cleaning was performed with reference to the criteria used in previous studies [ 32 , 33 ]. Values greater than the limit of detection (LOD) in the raw data of each group were chosen for (semi-) quantification.…”
Section: Methodsmentioning
confidence: 99%
“…Decreased PC was previously observed in MM cells compared to normal plasma cells [8]. Recently, Steiner et al reported significantly lower circulating plasma levels of several PCs, and elevated lyso-PCs in RRMM compared to NDMM [27]. Hydrolysis of PCs by phospholipases generate lyso-PCs and a free fatty acid which could be further processed to generate lipid second messengers such as arachidonic acid, prostaglandins and leukotrienes [28].…”
Section: Discussionmentioning
confidence: 96%
“…Recently, Steiner et al . reported significantly lower circulating plasma levels of several PCs, and elevated lyso-PCs in RRMM compared to NDMM [27]. Hydrolysis of PCs by phospholipases generate lyso-PCs and a free fatty acid which could be further processed to generate lipid second messengers such as arachidonic acid, prostaglandins and leukotrienes [28].…”
Section: Discussionmentioning
confidence: 99%